Tag Archives: Healthcare

Telos Launches The Epios Project to Facilitate COVID-19 Testing; Suvi Rinkinen, Douglas Horn Quoted

Telos

Telos has launched The Epios Project, designed to facilitate anonymous testing for COVID-19 and other epidemics, on Thursday. Within the project, Telos will utilize a mobile app to connect  anonymous testers with providers that supply and process test kits in compliance with local requirements.

Read More »

Unisys Supports Cyber4Healthcare to Enhance Cybersecurity Across Healthcare Providers; Tom Patterson, Stéphane Duguin Quoted

Tom Patterson

Unisys Corporation has announced its support of the CyberPeace Institute's Cyber4Healthcare initiative, a program designed to offer free cybersecurity services to healthcare providers fighting the COVID-19 pandemic, Unisys reported on Tuesday

Read More »

Siemens Healthineers Secures FDA EUA for SARS-CoV-2 Total Antibody Test; Deepak Nath Quoted

Deepak Nath

Siemens Healthineers has announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for its laboratory-based total antibody test to detect the presence of SARS-CoV-2 antibodies including IgM and IgG in blood, Siemens reported on Monday

Read More »

COVID-19 Healthcare Coalition Develops COVID-19 Decision Support Dashboard to Enhance Situational Awareness; Dr. John Halamka, Dr. Jay Schnitzer Quoted

Dr. John Halamka

The COVID-19 Healthcare Coalition published the COVID-19 Decision Support Dashboard to synthesize large amounts of complex, essential data into easy-to-use key findings for public and private-sector leaders navigating the “reopening” of communities and businesses, Mitre reported on Thursday.

Read More »

HHS Seeks Research to Support Health Care Amid COVID-19 Effects

The Department of Health and Human Services (HHS) plans to invest $5M in research to fortify U.S. health care against the COVID-19 pandemic. HHS said Thursday that its Agency for Healthcare Research and Quality seeks multi-method, coronavirus-related studies that would generate initial results within six months.

Read More »

FDA Approves NASA’s VITAL Under EUA to Combat COVID-19; Jim Bridenstine, Michelle Easter Quoted

NASA engineers have developed a new high-pressure ventilator to treat COVID-19 patients and it has been approved by the Food and Drug Administration (FDA) for under the ventilator Emergency Use Authorization (EUA), the administration announced on Friday.

Read More »

HUD, Salient CRGT Become Top Finalist for the ACT-IAC Igniting Innovation 2020; Atacan Donmez Quoted

Salient CRGT has announced that the company’s partnering client, the Department of Housing and Urban Development (HUD), has ranked as a top finalist for the ACT-IAC Igniting Innovation 2020 Conference and Awards for the Unisys Migration Project (UMP) – Technology Modernization Fund (TMF), Salient CRGT reported on Thursday.

Read More »

UiPath Partners with Swiftqueue to Expedite Healthcare System During COVID-19 Pandemic; Ian McGregor, Brendan Casey Quoted

https://executivegov-media.s3.amazonaws.com/2020/05/13/38/94/28/cb/4b/d7/da/04/uipath-partners-with-swiftqueue-to-expedite-healthcare-system-during-covid-19-pandemic-ian-mcgregor-brendan-casey-quoted.jpg

UiPath has partnered with Swiftqueue, the cloud-based scheduling platform for healthcare, to support patients and hospitals, and create significant savings amidst the COVID-19 pandemic, the company announced on Wednesday

Read More »

FDA Advances Serological Test Validation, Educational Efforts During COVID-19 Pandemic

fda-advances-serological-test-validation-educational-efforts-during-covid-19-pandemic

The FDA has announced that the administration will expand access to serology tests and its approach to making accurate and reliable serology tests widely available, while also protecting Americans from tests marketed with false or unsubstantiated claims, the FDA announced on Saturday.

Read More »

FDA Accepts Regeneron Pharmaceuticals’ Biologics License Application for REGN-EB3 to Treat Quickly-Spreading Pathogens; Dr. George Yancopoulos Quoted

fda-accepts-regeneron-pharmaceuticals-biologics-license-application-for-regn-eb3-to-treat-quickly-spreading-pathogens-dr-george-yancopoulos-quoted

Regeneron Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review a new Biologics License Application (BLA) for REGN-EB3, an investigational triple antibody treatment for Ebola virus infection, the company announced on Thursday

Read More »